PIK3CA and neoplasm: In contrast to knock-down of PIK3CA in HCT116, nude mice bearing subcutaneous tumors resulting from injected HCT116 BRAF-inducible shRNAs cells, when treated with dox showed a delay in tumor growth (Figure 2D).